Dailypharm Live Search Close

Organon¡¯s spinoff from MDS to be completed in June

By Eo, Yun-Ho | translator Alice Kang

21.05.23 12:04:18

°¡³ª´Ù¶ó 0
Spinoff to be completed at headquarters by next month¡¦ procedures such as transfer of licenses etc. remain in Korea

Moved into the Gwanghwamun office last year¡¦ will focus on women¡¯s health and biosimilars


Organon¡¯s spinoff from MSD will soon be complete.

Industry sources expect the administrative spin-off at the global headquarters of MSD and Organon to be completed within the next month (June). Following the spinoff, Organon & Co. will launch as a completely independent corporation in Korea as well.

Organon¡¯s Korean subsidiary has already moved into the shared office 'WeWork Gwanghwamun¡¯ located in The K Twin Tower in Junghak-dong, Jongno-gu, Seoul last year, and has undergone the necessary processes for its separation.

However, the legal procedures of the spinoff may take a while. Organon is currently undergoing procedures to change the license holder for its products,

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)